Chiun‐Fang Chiou

3.9k total citations · 1 hit paper
45 papers, 3.0k citations indexed

About

Chiun‐Fang Chiou is a scholar working on Rheumatology, Economics and Econometrics and Physiology. According to data from OpenAlex, Chiun‐Fang Chiou has authored 45 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 10 papers in Economics and Econometrics and 9 papers in Physiology. Recurrent topics in Chiun‐Fang Chiou's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Dermatology and Skin Diseases (7 papers). Chiun‐Fang Chiou is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Dermatology and Skin Diseases (7 papers). Chiun‐Fang Chiou collaborates with scholars based in United States, Canada and South Korea. Chiun‐Fang Chiou's co-authors include Joshua J. Ofman, Kathleen M. Fox, Sally Wade, Nathorn Chaiyakunapruk, Surachai Kotirum, Siew Li Teoh, David Bin‐Chia Wu, Huey Yi Chong, James M. Henning and Peter J. Neumann and has published in prestigious journals such as Gastroenterology, Journal of Allergy and Clinical Immunology and Journal of the American Geriatrics Society.

In The Last Decade

Chiun‐Fang Chiou

45 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global economic burden of schizophrenia: a systematic review

2016 460 citations Chiun‐Fang Chiou et al. Neuropsychiatric Disease and Treatment profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chiun‐Fang Chiou United States	26	684	573	501	482	410	45	3.0k
Arthur S. Zbrozek United States	16	346 0.5×	499 0.9×	468 0.9×	217 0.5×	207 0.5×	27	3.3k
Andrew G. Bushmakin United States	33	589 0.9×	309 0.5×	1.0k 2.0×	198 0.4×	322 0.8×	155	3.6k
Andrew P. Yu United States	33	302 0.4×	476 0.8×	241 0.5×	719 1.5×	201 0.5×	80	3.7k
Kimberly Webster United States	25	359 0.5×	298 0.5×	424 0.8×	206 0.4×	583 1.4×	55	5.2k
Jakob Kjellberg Denmark	32	529 0.8×	236 0.4×	498 1.0×	367 0.8×	329 0.8×	149	3.8k
Jill M. Killian United States	45	267 0.4×	255 0.4×	842 1.7×	165 0.3×	344 0.8×	122	6.1k
Enrico Cagliero United States	41	785 1.1×	194 0.3×	905 1.8×	154 0.3×	302 0.7×	82	6.2k
Xiaolei Zhou United States	26	802 1.2×	124 0.2×	409 0.8×	111 0.2×	465 1.1×	93	4.1k
Eunice Chang United States	31	426 0.6×	173 0.3×	550 1.1×	84 0.2×	326 0.8×	161	4.3k
Rob Riemsma United Kingdom	22	265 0.4×	194 0.3×	110 0.2×	234 0.5×	209 0.5×	51	1.8k

Countries citing papers authored by Chiun‐Fang Chiou

Since Specialization

Citations

This map shows the geographic impact of Chiun‐Fang Chiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiun‐Fang Chiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiun‐Fang Chiou more than expected).

Fields of papers citing papers by Chiun‐Fang Chiou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiun‐Fang Chiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiun‐Fang Chiou. The network helps show where Chiun‐Fang Chiou may publish in the future.

Co-authorship network of co-authors of Chiun‐Fang Chiou

This figure shows the co-authorship network connecting the top 25 collaborators of Chiun‐Fang Chiou. A scholar is included among the top collaborators of Chiun‐Fang Chiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiun‐Fang Chiou. Chiun‐Fang Chiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heß, Georg, Simon Rule, Wojciech Jurczak, et al.. (2017). Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus. Leukemia & lymphoma. 58(12). 2824–2832. 15 indexed citations

Chiou, Chiun‐Fang, et al.. (2015). The cost reduction in hospitalization associated with paliperidone palmitate in the People’s Republic of China, Korea, and Malaysia. Neuropsychiatric Disease and Treatment. 11. 1989–1989. 9 indexed citations

Roberts, Nicola, James Lewsey, Michelle Gillies, et al.. (2013). Time trends in 30 day case-fatality following hospitalisation for asthma in adults in Scotland: A retrospective cohort study from 1981 to 2009. Respiratory Medicine. 107(8). 1172–1177. 15 indexed citations

Bushnell, Donald M., Mona L. Martin, Kelly P. McCarrier, et al.. (2012). Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity. Journal of Dermatological Treatment. 24(5). 356–360. 50 indexed citations

Cawthon, Peggy M., Kathleen M. Fox, Shravanthi R. Gandra, et al.. (2011). Clustering of Strength, Physical Function, Muscle, and Adiposity Characteristics and Risk of Disability in Older Adults. Journal of the American Geriatrics Society. 59(5). 781–787. 69 indexed citations

Meltzer, Eli O., William W. Busse, Sally E. Wenzel, et al.. (2010). Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation. Journal of Allergy and Clinical Immunology. 127(1). 167–172. 91 indexed citations

Seliger, Stephen L., Kathleen M. Fox, Shravanthi R. Gandra, et al.. (2010). Timing of Erythropoiesis-Stimulating Agent Initiation and Adverse Outcomes in Nondialysis CKD. Clinical Journal of the American Society of Nephrology. 5(5). 882–888. 17 indexed citations

Fox, Kathleen M., John M. Brooks, Shravanthi R. Gandra, Richárd Márkus, & Chiun‐Fang Chiou. (2009). Estimation of Cachexia among Cancer Patients Based on Four Definitions. Journal of Oncology. 2009. 1–7. 110 indexed citations

Cawthon, Peggy M., Kathleen M. Fox, Shravanthi R. Gandra, et al.. (2009). Do Muscle Mass, Muscle Density, Strength, and Physical Function Similarly Influence Risk of Hospitalization in Older Adults?. Journal of the American Geriatrics Society. 57(8). 1411–1419. 332 indexed citations

10.

Gelfand, Joel M., Alexa B. Kimball, Eliot N. Mostow, et al.. (2007). Patient-Reported Outcomes and Health-Care Resource Utilization in Patients with Psoriasis Treated with Etanercept: Continuous versus Interrupted Treatment. Value in Health. 11(3). 400–407. 51 indexed citations

11.

Doan, Quan V., Chiun‐Fang Chiou, & Robert W. Dubois. (2006). Review of Eight Pharmacoeconomic Studies of the Value of Biologic DMARDs Adalimumab, Etanercept, and Infliximab) in the Management of Rheumatoid Arthritis. Journal of Managed Care Pharmacy. 12(7). 555–569. 64 indexed citations

12.

Nordyke, Robert J., et al.. (2006). Validation of a patient satisfaction questionnaire for anemia treatment, the PSQ-An. Health and Quality of Life Outcomes. 4(1). 28–28. 9 indexed citations

13.

Dubinsky, Marla C., Eileen Reyes, Joshua J. Ofman, et al.. (2005). A Cost-Effectiveness Analysis of Alternative Disease Management Strategies in Patients with Crohn's Disease Treated with Azathioprine or 6-Mercaptopurine. The American Journal of Gastroenterology. 100(10). 2239–2247. 128 indexed citations

14.

Chiou, Chiun‐Fang, Joel W. Hay, Joel Wallace, et al.. (2003). Development and Validation of a Grading System for the Quality of Cost-Effectiveness Studies. Medical Care. 41(1). 32–44. 248 indexed citations

15.

Ofman, Joshua J., Sean D. Sullivan, Peter J. Neumann, et al.. (2003). Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES. Journal of Managed Care Pharmacy. 9(1). 53–61. 283 indexed citations

16.

Weisman, Michael H., Simcha M. Russak, Deborah P. Lubeck, et al.. (2003). Development of a new instrument for rheumatoid arthritis: The Cedars‐Sinai Health‐Related Quality of Life instrument (CSHQ‐RA). Arthritis Care & Research. 49(1). 78–84. 8 indexed citations

17.

Borenstein, Jeff, Chiun‐Fang Chiou, James M. Henning, et al.. (2003). Physician attitudes toward strategies to promote the adoption of medical evidence into clinical practice.. PubMed. 9(3). 225–34. 12 indexed citations

18.

Weingarten, Scott, Lynne E. Lloyd, Chiun‐Fang Chiou, & Glenn D. Braunstein. (2002). Do Subspecialists Working Outside of Their Specialty Provide Less Efficient and Lower-Quality Care to Hospitalized Patients Than Do Primary Care Physicians?. Archives of Internal Medicine. 162(5). 527–527. 34 indexed citations

19.

Ofman, Joshua J., Joel Wallace, Enkhe Badamgarav, et al.. (2002). The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage. The American Journal of Gastroenterology. 97(8). 1941–1950. 18 indexed citations

20.

Fass, Ronnie, George F. Longstreth, Mark Pimentel, et al.. (2001). Evidence- and Consensus-Based Practice Guidelines for the Diagnosis of Irritable Bowel Syndrome. Archives of Internal Medicine. 161(17). 2081–2081. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact